2021 Featured Speakers

Brian K. Goodger
Acting Director

RADM Denise Hinton
Chief Scientist

Dr. Marcella Nunez-Smith
COVID-19 Equity Task Force Chair
Dept. of Health and Human Services

2021 Featured Sessions

Public Health Information: From Knowledge to Action
The importance of transparent and readily understandable public health information has never been more evident than today’s continuing response to the COVID-19 pandemic. Discover what public health information challenges federal agencies are facing, what initiatives/challenges need to be addressed to better gain public acceptance of programs and more. Read more.

Role of Data and Evidence-Based Policymaking
From supporting groundbreaking clinical research, to evaluating the impact of nutrition assistance programs, companies are providing health and social policy research solutions to policy makers in the United States and around the world. This session will examine future government needs, how data is shaping policy frameworks, and how industry and government are developing comprehensive, multi-disciplinary solutions to today’s real-life challenges. Read more.

Acquisition Insights
Acquisition officials will discuss an overview of the procurement landscape. Learn what to expect for the remainder of FY21 and into FY22. Read more.


See Who's Attending the 2021 FedHealth Conference

2021 Planning Committee


Kathy Taylor
DRT Strategies

Committee Members
Rachel Jenkins, Avascent
Matt Smith, Business Acumen 
Mitch Newman, Dell Federal
Kim McCarley, ICF
Helene Fisher, DLH Corp
Kathy Lentz, Federal Insights
Arit Arthur, IBM
Janet Webb, LMI
Jean-Marie Mayas, The MayaTech Corporation


2021 Premier Sponsors

As Featured In


View all sponsorsClick here for 2021 sponsorship opportunities.

Click here to view the Social Media Toolkit

2021 Thought Leadership Compendium

Click here to view the 2021 Thought Leadership Compendium. Special thanks to Capgemini, Dovel Technologies, ICF, J.P. Morgan, Leidos, LMI and MayaTech Corporation for submitting research on significant topics within the federal health industry.